Gastón Paladini, Co-Founder and CEO of Moolec Science Limited
(“Moolec”) attended the two-day Future Food-Tech Alternative
Proteins Summit in New York this week, where he joined fellow
industrial thought leaders, and highlighted the promise of
Molecular Farming to helping address the challenge of food
security.
“Moolec is a science-based food ingredient
company, using Molecular Farming” Paladini told the summit in his
presentation ‘Molecular Farming: Producing Meat Molecules with
Plants’ on June 21. “We focus on scale and cost because that is the
main goal: to feed the world, to feed more than 10 billion people
in 2050. We are really focused on getting a more resilient,
sustainable and equitable food system.”
The Future Food-Tech Alternative Proteins Summit
was held from June 21 to 22, 2022 at the New York Marriott at the
Brooklyn Bridge with participation from more than 800 people, both
virtually and in person. Moolec’s CEO joined other C-Suite
executives, investors, and entrepreneurs from all four corners of
the globe to accelerate new partnerships and collaborate on
opportunities.
Paladini’s speech showcased Moolec’s platform
that expresses animal proteins by growing genetically engineered
crops containing bovine and porcine proteins, and how this new
technology can improve all aspects of meat alternatives, from how
they are produced until the final customers’ experience.
Molecular Farming technology is unique in its
ability to capitalize on the scale that extensive agriculture
entails to achieve affordability. It is also cost-efficient because
it leverages biology, using plants and their inputs – sun, water,
and soil – as small factories for the production of animal
proteins. The Company's first two products are Chymosin SPC, a
bovine protein expressed in safflower that has curdling
applications in the cheese industry, and gamma-linoleic acid (GLA),
a nutritional oil technology sourced from Bioceres Crop Solutions
(Nasdaq:BIOX)..
Moolec has accelerated product development
efforts to widen its technology reach, by using the two crops that
are most broadly used as protein alternatives – soy and peas – to
develop actual meat proteins.
Through this type of “food hacking”, Molecular
Farming promises to transform food production, Paladini said.
“We are food hackers,” Paladini told the summit.
“We are hacking the system from the inside by using the link of the
current value chain. But we reverse the logic. Instead of feeding
animals with plant proteins, we could say that we are feeding
plants with animal proteins.”
On June 15, 2022 Moolec announced the entry into
a definitive agreement with LightJump Acquisition Corp. (Nasdaq:
LJAQ; “LightJump”) for a business combination that would result in
Moolec Science SA (the “Company”), a newly created affiliate of
Moolec incorporated in Luxembourg, becoming a publicly listed
company (the “Transaction”).
About Moolec Science
Moolec is a science-based ingredient company
focused on producing real animal proteins in plants through
Molecular Farming, a disruptive technology in the alternative
protein landscape. Its purpose is to upgrade taste, nutrition, and
affordability of alternative protein products while building a more
sustainable and equitable food system. The company’s technological
approach aims to have the cost structure of plant-based solutions
with the organoleptic properties and functionality of animal-based
ones. Moolec’s technology has been under development for more than
a decade and is known for pioneering the production of a bovine
protein in a crop for the food industry. Moolec is run by a diverse
team of Ph.Ds and Food Insiders, and operates in the United States,
Europe, and South America. For more information, visit
www.moolecscience.com.
About LightJump Acquisition
Corp.
LightJump is a Delaware blank check company
incorporated on July 28, 2020 formed for the purpose of entering
into a merger, share exchange, asset acquisition, stock purchase,
recapitalization, reorganization or other similar business
combination with one or more target businesses. For more
information, visit
www.lightjumpcap.com/lightjump-acquisition-corp
Forward Looking Statements
This press release contains “forward-looking
statements.” Forward-looking statements may be identified by the
use of words such as "forecast," "intend," "seek," "target,"
“anticipate,” “believe,” “expect,” “estimate,” “plan,” “outlook,”
and “project” and other similar expressions that predict or
indicate future events or trends or that are not statements of
historical matters. For example, statements concerning the
following include forward looking statements: the growth of
Moolec’s business and its ability to realize expected results; the
business model of Moolec relating to any partnerships, commercial
contracts, regulatory approvals or patent filings; the viability of
its growth and commercial strategy; financial projections; the
success, cost and timing of its product development abilities; the
advantages and potential of Moolec’s technology and products,
including in comparison to competing technologies and products;
trends and developments in the industry; the addressable market;
the contemplated transaction among Moolec and LightJump; Moolec’s
addressable market; and the potential effects of the business
combination among Moolec and LightJump. Such forward-looking
statements with respect to performance, prospects, revenues, and
other aspects of the business of Moolec or LightJump are
predictions, projections and other statements about future events
that are based on current expectations and assumptions and, as a
result, are subject to risks and uncertainties. Although we believe
that we have a reasonable basis for each forward-looking statement
contained in this press release, we caution you that these
statements are based on a combination of facts and factors, about
which we cannot be certain. These factors include, but are not
limited to: (1) the inability to complete the transactions
contemplated by the proposed business combination, resulting in the
Combined Company with the expectation to be listed on Nasdaq; (2)
the inability to recognize the anticipated benefits of the proposed
business combination, which may be affected by, among other things,
competition, and the ability of the combined business to grow and
manage growth profitably; (3) the inability to successfully retain
or recruits officers, key employees, or directors following the
proposed business combination; (4) effects on LightJump’s public
securities’ liquidity and trading; (5) the market’s reaction to the
proposed business combination; (6) the lack of a market for
LightJump’s securities; (7) Moolec’s and LightJump’s financial
performance following the proposed business combination; (8) costs
related to the proposed business combination; (9) changes in
applicable laws or regulations; (10) the possibility that LightJump
or Moolec may be adversely affected by other economic, business,
and/or competitive factors; (11) the risk that Moolec is unable to
successfully develop and commercialize Moolec’s products or
services or experience significant delays; (12) the risk of product
liability or regulatory lawsuits relating to Moolec’s products and
services; (13) the risk that Moolec is unable to secure or protect
its intellectual property; (14) the ability to maintain the listing
of LightJump’s securities on Nasdaq and (15) the ability for the
Company’s securities to be approved for listing on Nasdaq or if
approved, maintain the listing. The foregoing list of factors is
not complete or exhaustive. You should carefully consider the
foregoing factors as well as other risks and uncertainties
described in the “Risk Factors” section of LightJump’s Annual
Report on Form 10-K, Quarterly Reports on Form 10-Q and in the
final prospectus of LightJump related to its initial public
offering filed with the SEC. You should also carefully consider the
other risks and uncertainties indicated from time to time in
documents filed or to be filed with the SEC by LightJump and the
Form F-4 and proxy statement to be filed with the SEC by the
Company and LightJump. Should one or more of these risks or
uncertainties materialize, or should any of our assumptions prove
incorrect, actual results may vary in material respects from those
projected in these forward-looking statements. We undertake no
obligation to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise,
except as may be required under applicable securities laws.
Accordingly, you should not put undue reliance on these
statements.
Important Additional Information
Regarding the Transaction Will Be Filed With the SEC
In connection with the proposed transaction, the
Company is expected to file a registration statement on Form F-4
with the SEC that will include a prospectus with respect to the
Company’s securities to be issued in connection with the proposed
transaction and a proxy statement with respect to the shareholder
meeting of LightJump Acquisition Corp. to vote on the proposed
transaction. Shareholders of LightJump Acquisition Corp. and other
interested persons are encouraged to read, when available, the Form
F-4, including the preliminary proxy statement/prospectus and
amendments thereto and the definitive proxy statement/prospectus
and documents incorporated by reference therein as well as other
documents to be filed with the SEC in connection with the proposed
transaction because these documents will contain important
information about LightJump Acquisition Corp., Moolec Science, and
the proposed transaction. After the registration statement is
declared effective, the definitive proxy statement/prospectus to be
included in the registration statement will be mailed to
shareholders of LightJump Acquisition Corp. as of a record
date to be established for voting on the proposed transaction. Once
available, shareholders of LightJump Acquisition Corp. will
also be able to obtain a copy of the F-4, including the proxy
statement/prospectus, and other documents filed with the SEC
without charge, by directing a request to: 101 Natoma St., 2F, San
Francisco, CA 94105. The preliminary and definitive proxy
statement/prospectus to be included in the registration statement,
once available, can also be obtained, without charge, at the SEC’s
website www.sec.gov.
Participants in the
Solicitation
The Company and Moolec Science and their
respective directors and executive officers may be considered
participants in the solicitation of proxies with respect to the
potential transaction described in this communication under the
rules of the SEC. Information about the directors and executive
officers of LightJump Acquisition Corp. and their ownership
is set forth in LightJump Acquisition Corp. ’s filings with the
SEC, including its Form 10-K for the year ended December 31, 2021
and subsequent filings under section 16 of the Exchange Act or on
Form 10-Q. Additional information regarding the persons who may,
under the rules of the SEC, be deemed participants in the
solicitation of LightJump Acquisition Corp.’s shareholders in
connection with the potential transaction will be set forth in the
registration statement containing the preliminary proxy
statement/prospectus when those are filed with the SEC. These
documents are available free of charge at the SEC’s website at
www.sec.gov or by directing a request to: 101 Natoma St., 2F, San
Francisco, CA 94105.
No Offer or Solicitation
This communication is not a proxy statement or
solicitation of a proxy, consent or authorization with respect to
any securities or in respect of the potential transaction and does
not constitute an offer to sell or a solicitation of an offer to
buy any securities of Company or Moolec Science, nor shall there be
any sale of any such securities in any state or jurisdiction in
which such offer, solicitation or sale would be unlawful prior to
registration or qualification under the securities laws of such
state or jurisdiction. No offer of securities shall be made except
by means of a prospectus meeting the requirements of the Securities
Act.
Moolec Science Media
Contacts
- Catalina Jonescomms@moolecscience.com
- Edmond LococoMoolecPR@icrinc.com
Moolec Science and LightJump Acquisition
Corp. Investor Contact:
- Michael Bowen, ICR, LLCMoolecIR@icrinc.com
LightJump Acquisition (NASDAQ:LJAQ)
Historical Stock Chart
From May 2024 to Jun 2024
LightJump Acquisition (NASDAQ:LJAQ)
Historical Stock Chart
From Jun 2023 to Jun 2024